Article
Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice.
Journal of neuroinflammation - 25 May 2017
Qu Wenhui, Johnson Andrea, Kim Joo Hyun, Lukowicz Abigail, Svedberg Daniel, Cvetanovic Marija
Abstract excerpt
BACKGROUND: Polyglutamine (polyQ) expansion in the protein Ataxin-1 (ATXN1) causes spinocerebellar ataxia type 1 (SCA1), a fatal dominantly inherited neurodegenerative disease characterized by motor deficits, cerebellar neurodegeneration, and gliosis. Currently, there are no treatments available to delay or ameliorate SCA1. We have examined the effect of depleting microglia during the early stage of disease by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
